Clare Market Investments LLC Takes Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Clare Market Investments LLC purchased a new stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 91,381 shares of the pharmacy operator’s stock, valued at approximately $853,000.

Other hedge funds have also recently made changes to their positions in the company. First Financial Corp IN boosted its stake in shares of Walgreens Boots Alliance by 49.2% during the fourth quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator’s stock valued at $25,000 after purchasing an additional 885 shares in the last quarter. Golden State Wealth Management LLC acquired a new stake in shares of Walgreens Boots Alliance during the fourth quarter valued at about $26,000. Riverview Trust Co boosted its stake in shares of Walgreens Boots Alliance by 123.8% during the fourth quarter. Riverview Trust Co now owns 2,874 shares of the pharmacy operator’s stock valued at $27,000 after purchasing an additional 1,590 shares in the last quarter. Venturi Wealth Management LLC acquired a new position in shares of Walgreens Boots Alliance in the fourth quarter worth approximately $28,000. Finally, TD Private Client Wealth LLC lifted its stake in shares of Walgreens Boots Alliance by 8,670.3% in the third quarter. TD Private Client Wealth LLC now owns 3,245 shares of the pharmacy operator’s stock worth $29,000 after acquiring an additional 3,208 shares during the period. 58.59% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

WBA has been the topic of a number of recent analyst reports. Truist Financial cut their price objective on Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating on the stock in a research note on Friday, January 31st. Evercore ISI lifted their price objective on Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an “in-line” rating in a research note on Monday, January 13th. Deutsche Bank Aktiengesellschaft lowered Walgreens Boots Alliance from a “hold” rating to a “sell” rating and cut their price objective for the stock from $11.00 to $9.00 in a research note on Friday, February 28th. Bank of America lifted their price objective on Walgreens Boots Alliance from $7.50 to $8.50 and gave the stock an “underperform” rating in a research note on Monday, January 13th. Finally, Wolfe Research raised Walgreens Boots Alliance to a “hold” rating in a research note on Monday, February 24th. Four investment analysts have rated the stock with a sell rating, eight have given a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $11.54.

Walgreens Boots Alliance Trading Up 7.5 %

NASDAQ WBA opened at $11.39 on Monday. The company has a market cap of $9.84 billion, a price-to-earnings ratio of -1.11, a P/E/G ratio of 1.31 and a beta of 0.62. Walgreens Boots Alliance, Inc. has a 52 week low of $8.08 and a 52 week high of $22.05. The business has a 50 day moving average price of $10.64 and a 200-day moving average price of $9.71. The company has a quick ratio of 0.30, a current ratio of 0.64 and a debt-to-equity ratio of 0.68.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings data on Friday, January 10th. The pharmacy operator reported $0.51 EPS for the quarter, beating the consensus estimate of $0.38 by $0.13. The firm had revenue of $39.50 billion during the quarter, compared to the consensus estimate of $37.40 billion. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The company’s quarterly revenue was up 7.6% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.66 earnings per share. As a group, equities analysts expect that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current fiscal year.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.